Clinical Indicators of Genetic PC The cerebral palsy (CP) is a neurological condition that can be caused by both acquired and genetic factors. Identifying clinical indicators associated with genetic CP may facilitate the selection of candidates for genetic testing. In this article, the clinical indicators that may suggest a …
Category archives: Neurological diseases
GMFCS E&R.
Clinical Guideline on GMFCS E&R The Global Motor Function Classification System (GMFCS) is a system used to classify the severity of motor disability in children with neurological disorders. The Evaluation and Recommendations (E&R) System complements the GMFCS by providing more detailed and practical guidance for the classification and management of these…
Do animals have autism?
Introduction to Autism Spectrum Disorder (ASD) The diagnosis of autism spectrum disorder (ASD) is based on the presence of two symptom dimensions: stereotyped and repetitive behaviors, inflexibility, restricted interests, and difficulties in social interaction, nonverbal communication, and socioemotional reciprocity. Stereotyped and Repetitive Behaviors …
Congenital (infantile/infant) nystagmus.
Introduction to Congenital Infantile Nystagmus Congenital nystagmus is an ocular disorder characterized by involuntary eye movements that can be diagnosed in the first months of life. These movements may indicate a variety of neurological, genetic, or ocular conditions. Proper evaluation and treatment are crucial to prevent complications and promote optimal development …
Continue reading «Nistagmo congénito (infantil/del lactante).»
Infantile hemangioma.
Infantile Hemangioma Infantile hemangioma is the most common benign vascular tumor in pediatric age. It is typically not present at birth, but manifests in the first weeks of life as an erythematous macule that progresses to a bright red raised lesion. Clinical Phases Proliferative Phase: Rapid growth during the first 5...
Mitochondrial diseases.
Mitochondrial diseases are a group of genetic disorders that affect the mitochondria, the cellular structures responsible for producing energy in the form of ATP (adenosine triphosphate). These diseases are caused by mutations in mitochondrial DNA or in nuclear genes that encode proteins related to mitochondrial function. Because mitochondria are…
Coenzyme Q10 (Decorenone).
Coenzyme Q10: Deficiency and Treatment in Pediatric Neurology Introduction Coenzyme Q10 (CoQ10), also known as Decorenone, is an essential compound for cellular function, particularly in tissues with high energy demands such as the brain and muscles. CoQ10 deficiency may manifest as cerebellar ataxia, encephalomyopathy, myopathy, among other neurological syndromes. …
Protocols SENEP
Protocols of the Spanish Society of Pediatric Neurology (SENEP): Pillars of childhood neurological management The protocols of the Spanish Society of Pediatric Neurology (SENEP) constitute a standardized and evidence-based guide for the diagnosis, management and monitoring of neurological pathologies in childhood, integrating anatomophysiological, clinical and evolutionary aspects essential for pediatric practice. …
Protocol SENEO 2023
Protocols of the Spanish Society of Neonatology (SENEO) 2023 The protocols of the Spanish Society of Neonatology (SENEO) in its 2023 update include national recommendations based on evidence on the comprehensive clinical care of the full-term and preterm newborn. These protocols address several important areas, including: Neonatal resuscitation: Provides updated guidelines for…
Metabolic diseases with dysmorphia.
In Vademecum Metabolicum there are different guides depending on the clinical scenario, including metabolic diseases that present with dysmorphia:
